CA
NZ
UK
AU
IND
US
Director Judson Gray Teekell filed a Form 4 with the SEC on November 9, 2026, disclosing two transactions dated November 5, 2026, involving Common Stock of Miami International Holdings, Inc. tied to the distribution of the Estate of Byrum W. Teekell.
Rapid7, Inc. Executive Chairman Corey E. Thomas filed a Form 4 on November 9, 2026, disclosing the exercise of 134,000 non-qualified stock options and a share withholding transaction dated November 6, 2026.
Accenture plc Chief Financial Officer Angie Y. Park filed a Form 4 on November 9, 2026, disclosing the acquisition of 102 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.
Melissa A. Burgum, Chief Accounting Officer of Accenture plc (NYSE:ACN), filed a Form 4 on November 9, 2026, disclosing the acquisition of 75 Class A ordinary shares on November 5, 2026.
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, filed a Form 4 on November 9, 2026, disclosing the acquisition of 80 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.
Accenture plc Chair and CEO Julie Spellman Sweet filed a Form 4 on November 9, 2026, disclosing a purchase of 144 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.
John F. Walsh, CEO-Americas of Accenture plc, filed a Form 4 on November 9, 2026, disclosing a purchase of 103 Class A ordinary shares on November 5, 2026, through the Accenture Voluntary Equity Investment Program.
Accenture plc Chief Leadership and HR Officer Katherine Lee Clifford filed a Form 4 on November 9, 2026, disclosing a purchase of 65 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.
A Form 4 filed on November 9, 2026, discloses that Joel Unruch, General Counsel, Corporate Secretary, and Chief Risk Officer of Accenture plc (NYSE:ACN), acquired 102 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.
ADAR1 Capital Management, LLC filed a Form 4 on November 9, 2026, disclosing two open-market purchases of NextCure, Inc. common stock totaling 4,686 shares made on November 5 and November 6, 2026.
Please wait processing your request...